BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Promontory Therapeutics Announces Peer-Reviewed Publication in Cancers of Selective Effects of PT-112 in Cancer Cell Models Driven by Mitochondrial Dysfunction

  Promontory Therapeutics announced today the peer-reviewed publication of mechanistic studies with lead candidate PT-112 in this month’s issue of Cancers (volume 14, issue 16), an MDPI publication.

  August 11, 2022

   · 

  5 min read
• Business

  Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors

  Innovation1 Biotech Inc. today announced the appointment of the Company’s Chief Science Officer, Andrew L. Salzman, M.D., to its Board of Directors.

  August 11, 2022

   · 

  6 min read
• Business

  Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

  Wave Life Sciences Ltd. today announced financial results for the second quarter ended June 30, 2022 and provided a business update.

  August 11, 2022

   · 

  20 min read
• Business

  Solid Biosciences Provides Second Quarter 2022 Business Update and Financial Results

  Solid Biosciences Inc. today reported financial results for the second quarter ended June 30, 2022 and provided a business update.

  August 11, 2022

   · 

  8 min read
• Business

  Vaxxinity Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

  Vaxxinity, Inc. today reported financial results for the second quarter ended June 30, 2022.

  August 11, 2022

   · 

  8 min read
• Pharm Country

  U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

  Alliance Pharma (Alliance), a global leader in bioanalytical and CMC testing services in the pharmaceutical and biopharmaceutical industry, today announced they will be opening a bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.

  August 11, 2022

   · 

  2 min read
• Business

  PsiOxus Therapeutics Appoints Howard Davis, Ph.D. as Chief Executive Officer

  PsiOxus Therapeutics, Ltd. today announces the appointment of Howard Davis, Ph.D., as Chief Executive Officer.

  August 11, 2022

   · 

  5 min read
• Business

  UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

  UroGen Pharma Ltd. today announced financial results for the second quarter ended June 30, 2022 and provided an overview of recent developments.

  August 11, 2022

   · 

  18 min read
• Drug Development

  Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease

  Graphite Bio, Inc. today announced that the first patient has been dosed with GPH101, now called nulabeglogene autogedtemcel (nula-cel), in the company’s Phase 1/2 CEDAR trial in people with sickle cell disease (SCD).

  August 11, 2022

   · 

  6 min read
• Business

  Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

  Aptevo Therapeutics Inc. today reported financial results and business highlights for the quarter ended June 30, 2022.

  August 11, 2022

   · 

  11 min read